V the axons for COVID-19 will remain in the long run and could become part of the annual range of booster injections, leading vaccine manufacturers have predicted.
No one in Bulgaria has died from the COVID-19 vaccine
Manufacturers of mRNA vaccines Moderna and Pfizer are working on new versions of their vaccines aimed at tackling the Omicron variant.
Speaking at the World Economic Forum (WEF) on Monday, Moderna CEO Stefan Bansel said his company planned to offer a seasonal booster injection to cover COVID-19, as well as other respiratory diseases such as influenza and respiratory syncytial virus. (RSV).
Kunchev: Then it won’t matter if you’re with Omicron
“Our goal is to be able to offer one annual booster dose so that we don’t have problems with compliance when people don’t want to have two or three injections in the winter,” Ban was quoted as saying by Euronews.
Asked when the booster for COVID, influenza and RSV could be available, he replied that “at best, it would be in the autumn of 2023.”
COVID-19 pandemic that requires restrictions on work and social life.
Prime Minister Petkov also refused to revive Mangarov
“The most likely scenario is that the virus will continue to circulate for several years. It is a virus that has spread around the world and it is very difficult to get rid of it,” he said. “But I think with the tools that science has given us, this wave will be the last to bring with it that kind of limitation.”
EMA points to new side effect of AstraZeneca and Johnson & Johnson vaccines
Commenting to the French television operator BFM, Burla reiterated the opinion of the head of Moderna Bansel: “Annual vaccinations against COVID-19 will be a fact for years to come.”
“For me, the important thing is to turn the three doses into a full vaccination, followed by an annual dose, except for immunocompromised people, who could receive a booster every four months,” he said. / BGNES
